Pabotini

Related products

• 

  Breast cancer , Late childhood neuroblastoma

  Melphalan

  【Product name】Alkeran

  [English common name]Melphalan

  [Chinese common name]Melphalan

  [English name]Melphalan HCl, Melphalan 2HCl, l-phenylalanine mustard

  [Chinese other name]Melfal, Melphalan, cancer Kyan, Milfair

  [Indications] This product can be used with a variety of tumors, in single chemotherapy and combination chemotherapy,Multiple myelomaThe drug of choice. CorrectSpermato cell tumor,Breast cancer,Ovarian cancer,Chronic leukemia,Polycythemia vera,Malignant lymphoma,Late childhood neuroblastoma,Thyroid cancereffective. Arterial infusion for the treatment of limb malignancies such as malignant melanoma, soft tissue sarcoma and osteosarcoma has a good effect, even for the treatment of certain autoimmune diseases and to prevent rejection during organ transplantation.

  【Dosage】
  Multiple myeloma:
  A typical dose is 0.15 mg per kilogram of body weight per day, taken in four divided doses, and repeated for six weeks. Prolonged treatment for those who respond to treatment will not change the effect. The combination of melphalan and prednisone may be more effective than single use.
  Ovarian adenocarcinoma:
  A typical treatment regimen is 0.2 mg per kilogram of body weight per day for five days, repeated every 4 to 8 weeks or when the peripheral blood is restored; the dose should be reduced when bone marrow toxicity occurs.
  Advanced breast cancer:
  Oral melphalan daily 0.15 mg per kilogram of body weight or 6 mg per square meter of body surface area for a total of 5 days, repeated treatments every six weeks, can also be treated with intravenous melphalan.
  True erythrocytosis:
  Induction of remission, use 6 to 10 mg daily for 5 to 7 days, then 2 to 4 mg per day until the symptoms can be satisfactorily controlled. The maintenance dose can be 2 to 6 mg per week. Care must be taken during the patient. The hematology control is performed on the ground, and the dose is appropriately adjusted based on the blood cell count result.
  Patients with renal insufficiency:
  Based on current pharmacokinetic data, oral melphalan is not recommended for patients with moderate to severe renal insufficiency, but the initial dose should be carefully reduced.

  [Storage]Store in a dark, cool, dry place.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer , Myelodysplastic syndrome

  Azacitidine

  【Product name】VIDAZA 

  [English common name]Azacitidine

  [Chinese common name]Azacitidine

  [English name]

  [Chinese other name]

  [indications]Acute non-lymphocytic leukemia. Used forBreast cancer,Intestinal cancer,MelanomaWait for a certain effect.

  [Usage and dosage] 100mg/m2, intravenous bolus injection, once every 8 hours, for 5 days, 200mg / (m2 · d) intravenous infusion, for 5 days.

  [Storage] Vidaza should be re-injected with water. The shelf life of the reconstituted drug can be extended by reinjection with frozen (2 ° C to 8 ° C) water.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Ixapilone

  【Product name】Ixempra

  [English common name]Ixabepilone

  [Chinese common name]Ixapilone

  [English name]Ipsapironum

  [Chinese other name]1-dioxide

  [Indications] IXEMPRA combined with capecitabine for the treatment of metastatic or local advancedBreast cancerPatients who are resistant to anthracyclines and taxanes, or whose cancers have taxane resistance and are further contraindicated for their anthracycline treatment. Anthracycline resistance is defined as the progressive metastatic environment during treatment or within 6 months or within 3 months of the adjuvant treatment group. Taxane resistance is defined as progression at treatment or within 12 months of adjuvant therapy or at 4 months in a metastatic environment.
  IXEMPRA is indicated for the treatment of advanced breast cancer anthracyclines, taxanes and capecitabine in patients with metastatic or local monotherapy tumor-resistant or refractory patients.

  [Usage and Dosage] The recommended dose of IXEMPRA is 40 mg / m 2 and intravenous administration for 3 hours every 3 weeks. The dose of a patient with a body surface area (BSA) greater than 2.2 m2 should be calculated according to 2.2 m2.

  [Storage] The IXEMPRA kit must be stored in a refrigerator at 2 ° C to 8 ° C (36 ° F to 46 ° F). Keep the original packaging until it is used to prevent light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer , Renal cell carcinoma (RCC)

  Sorafenib

  【Product name】NEXAVAR

  [English common name]Sorafenib

  [Chinese common name]Sorafenib

  [English name]

  [Chinese other name]Solafini, sorafini monomer

  [indications]
  Sorafenib: TYKERB lapatinib is used in combination with capecitabine to treat ErbB-2 overexpression and has previously received advanced or metastatic treatments including anthracyclines, paclitaxel, and trastuzumab (Herceptin). SexBreast cancer.
  Sorafenib tosylate tablets: treatment of advanced surgeryRenal cell carcinoma.
  Nexavar (Sorafenib): Sorafenib has been approved for the treatment of advanced renal cell carcinoma (the most common type of kidney cancer). In addition, there are currently nearly 50 clinical trials in the world that use sorafenib to treat a variety of other cancers.

  【Dosage】
  Sorafenib: The recommended dose is 1250 mg, once a day, on days 1 to 21, with capecitabine 2000 mg/d, and on the first to 14 days in 2 divided doses. Lapatinib should be taken once a day. It is not recommended to take it in divided doses. Take 1 h before meals or 2 h after meals. If one dose is missed, the dose will not be doubled on the second day. Pregnancy level D, pregnant women are banned. It is unclear whether milk secretion is passed, and lactating women should stop breastfeeding. There were no significant differences between the elderly and young patients. Patients with severe kidney damage and dialysis have not been clinically tested, and patients with moderate to severe liver damage should be given a dose reduction.
  Sorafenib tosylate tablets:
  Recommended Dosage: It is recommended to take sorafenib for 0.4 g (2 x 0.2 g) each time, twice daily, on an empty stomach or with a low-fat, medium-fat diet.
  How to use: Oral, swallow with a cup of warm water.
  Treatment time: The treatment should be continued until the patient is unable to clinically benefit or tolerate the toxic reaction.
  Nexavar (Sorafenib): Patients should read the product instructions and patient instructions carefully before taking the drug. Patients should be advised to take effective contraception during the medication and to try to conceive after at least 2 weeks of discontinuation. Inform patients to take the medicine on an empty stomach. If the patient forgets to take the medicine, there is no need to increase the dose for the next dose. When the patient has a rash on the hands and feet during the medication, he should contact the doctor for treatment accordingly.

  [Storage]
  Sorafenib tosylate tablets: Store at a temperature below 25 ° C. Keep the drug out of the reach of children.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.